Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Human Gene Therapy|August 30, 2008
Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesotheliomaKaitlyn J Kelly, Yanghee Woo, Peter Brader, et al.
Surgery|December 8, 2007
Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virusShu-Fu Lin, Zhenkun Yu, Christopher Riedl, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivoShu-Fu Lin, Daniel L Price, Chun-Hao Chen, et al.
Surgery|January 25, 2015
Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosisClarisse Eveno, Kelly Mojica, Justin W Ady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter GenePeter Brader, Kaitlyn J Kelly, Nanhai Chen, et al.
BMC Genomics|July 9, 2009
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapyAndrea Worschech, Nanhai Chen, Yong A Yu, et al.
Virology|July 19, 2005
Virulence differences between monkeypox virus isolates from West Africa and the Congo basinNanhai Chen, Guiyun Li, M Kathryn Liszewski, et al.
Vaccine|November 27, 2007
Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3John D Osborne, Melissa Da Silva, A Michael Frace, et al.
Pageof 3